Next Article in Journal / Special Issue
Beliefs and Opinions of Health Care Workers and Students Regarding Influenza and Influenza Vaccination in Tuscany, Central Italy
Previous Article in Journal / Special Issue
Assaying the Potency of Influenza Vaccines
Article Menu

Export Article

Open AccessReview
Vaccines 2015, 3(1), 105-136; doi:10.3390/vaccines3010105

M2e-Based Universal Influenza A Vaccines

1
Inflammation Research Center, VIB, Technologiepark 927, B-9052 Ghent, Belgium
2
Department for Biomedical Molecular Biology, Ghent University, Technologiepark 927, B-9052 Ghent, Belgium
*
Author to whom correspondence should be addressed.
Academic Editor: Sarah Gilbert
Received: 8 December 2014 / Revised: 23 December 2014 / Accepted: 30 January 2015 / Published: 13 February 2015
(This article belongs to the Special Issue Influenza Vaccines)
View Full-Text   |   Download PDF [913 KB, uploaded 13 February 2015]   |  

Abstract

The successful isolation of a human influenza virus in 1933 was soon followed by the first attempts to develop an influenza vaccine. Nowadays, vaccination is still the most effective method to prevent human influenza disease. However, licensed influenza vaccines offer protection against antigenically matching viruses, and the composition of these vaccines needs to be updated nearly every year. Vaccines that target conserved epitopes of influenza viruses would in principle not require such updating and would probably have a considerable positive impact on global human health in case of a pandemic outbreak. The extracellular domain of Matrix 2 (M2e) protein is an evolutionarily conserved region in influenza A viruses and a promising epitope for designing a universal influenza vaccine. Here we review the seminal and recent studies that focused on M2e as a vaccine antigen. We address the mechanism of action and the clinical development of M2e-vaccines. Finally, we try to foresee how M2e-based vaccines could be implemented clinically in the future. View Full-Text
Keywords: matrix protein 2; influenza; vaccines matrix protein 2; influenza; vaccines
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Deng, L.; Cho, K.J.; Fiers, W.; Saelens, X. M2e-Based Universal Influenza A Vaccines. Vaccines 2015, 3, 105-136.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top